Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial.

Arthritis Rheumatol · 2026 · PMC12991919 · PMID 40693411

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among bio‐naïve individuals, abatacept was associated with lower all‐cause mortality than rituximab, whereas in the bio‐experienced stratum, reflecting potentially more refractory disease, the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.